⚕ GalenOps CRO console
← SITE014 (NLD)

SITE014-0419

completed
Study: A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer Phase III · Site: SITE014 (NLD) (Dr. Moreau) · consented 2023-08-10
Adverse events
7
Serious AEs
1
Open data queries
0
Luna dropout signal
–

Adverse events

moderate assessed 2026-08-18

Grade 2 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-09-25 (study day 39); relationship: not assessed

mild assessed 2026-08-18

Grade 1 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2023-10-14 (study day 58); relationship: not assessed

severe serious assessed 2026-08-18

Grade 3 Constipation — outcome: RECOVERED/RESOLVED; onset 2023-10-27 (study day 71); relationship: not assessed; serious criteria: hospitalization

moderate assessed 2026-08-18

Grade 2 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-11-09 (study day 84); relationship: not assessed

mild assessed 2026-08-18

Grade 1 Fatigue — outcome: RECOVERED/RESOLVED; onset 2023-12-22 (study day 127); relationship: N

moderate assessed 2026-08-18

Grade 2 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2024-01-12 (study day 148); relationship: not assessed

moderate assessed 2026-08-18

Grade 2 Anaemia — outcome: RECOVERED/RESOLVED; onset 2024-01-28 (study day 164); relationship: not assessed

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.